Tech Company Financing Transactions
Heat Biologics Funding Round
Private investors participated in a $2.8 million funding round for Heat Biologics. The round closed on 12/30/2011.
Transaction Overview
Company Name
Announced On
12/30/2011
Transaction Type
Venture Equity
Amount
$2,829,243
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
627 Davis Dr. 400
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Heat Biologics, a clinical-stage company, offers ImPACT, an adjuvant technology to identify oncology and infectious disease indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Wolf
Chief Scientific Officer
Jeffrey Hutchins
Vice President
Gary Vinson
VP - Bus. Development
Lori McDermott
VP - R & D
Matthew Seavey
Browse more venture capital transactions:
Prev: 12/29/2011: Uptake Medical venture capital transaction
Next: 12/30/2011: Scope 5 venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs